vTv Therapeutics (VTVT) Free Cash Flow (2014 - 2026)
vTv Therapeutics recorded quarterly Free Cash Flow of $9.2 million in Q1 2026, up 198.95% quarter-over-quarter from -$9.3 million in Q4 2025, and up 260.96% year-over-year from $2.5 million in Q1 2025.
vTv Therapeutics' Free Cash Flow history runs 13 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 260.96% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at -$10.4 million (up 55.98% YoY), while the FY2025 annual figure was -$25.3 million, changed 0.21% from the prior year.
- Free Cash Flow came in at $9.2 million for Q1 2026 at vTv Therapeutics, up from -$9.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $9.2 million in Q1 2026 to a low of -$9.3 million in Q4 2025.
- A 5-year average of -$4.5 million and a median of -$5.2 million in 2025 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 973.51% in 2023 and soared 260.96% in 2026, its largest moves.
- vTv Therapeutics' Free Cash Flow stood at -$6.9 million in 2022, then surged by 57.65% to -$2.9 million in 2023, then plunged by 65.58% to -$4.8 million in 2024, then slumped by 91.73% to -$9.3 million in 2025, then jumped by 198.95% to $9.2 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $9.2 million, -$9.3 million, and -$5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | 9.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.15 Mn |
| Mar 31, 2026 | 9.15 Mn |
| Dec 31, 2025 | -9.25 Mn |
| Dec 31, 2025 | -9.25 Mn |
| Sep 30, 2025 | -5.22 Mn |
| Sep 30, 2025 | -5.22 Mn |
| Jun 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | -5.10 Mn |
| Mar 31, 2025 | -5.69 Mn |
| Mar 31, 2025 | -5.69 Mn |
| Dec 31, 2024 | -4.83 Mn |
| Dec 31, 2024 | -4.83 Mn |
| Sep 30, 2024 | -6.42 Mn |
| Sep 30, 2024 | -6.42 Mn |
| Jun 30, 2024 | -6.73 Mn |
| Jun 30, 2024 | -6.73 Mn |
| Mar 31, 2024 | -7.34 Mn |
| Mar 31, 2024 | -7.34 Mn |
| Dec 31, 2023 | -2.91 Mn |
| Dec 31, 2023 | -2.91 Mn |
| Sep 30, 2023 | -4.83 Mn |
| Sep 30, 2023 | -4.83 Mn |
| Jun 30, 2023 | -6.17 Mn |
| Jun 30, 2023 | -6.17 Mn |
| Mar 31, 2023 | -5.17 Mn |
| Mar 31, 2023 | -5.17 Mn |
| Dec 31, 2022 | -6.88 Mn |
| Dec 31, 2022 | -6.88 Mn |
| Sep 30, 2022 | -8.83 Mn |
| Sep 30, 2022 | -8.83 Mn |
| Jun 30, 2022 | 706,000.00 |
| Jun 30, 2022 | 706,000.00 |
| Mar 31, 2022 | -1.02 Mn |
| Mar 31, 2022 | -1.02 Mn |
| Dec 31, 2021 | -6.42 Mn |
| Dec 31, 2021 | -6.42 Mn |
| Sep 30, 2021 | -3.59 Mn |
| Sep 30, 2021 | -3.59 Mn |
| Jun 30, 2021 | -4.00 Mn |
| Jun 30, 2021 | -4.00 Mn |
| Mar 31, 2021 | -5.30 Mn |
| Mar 31, 2021 | -5.30 Mn |
| Dec 31, 2020 | -2.21 Mn |
| Dec 31, 2020 | -2.21 Mn |
| Sep 30, 2020 | -5.43 Mn |
| Sep 30, 2020 | -5.43 Mn |
| Jun 30, 2020 | -4.79 Mn |
| Jun 30, 2020 | -4.79 Mn |
| Mar 31, 2020 | -5.56 Mn |
| Mar 31, 2020 | -5.56 Mn |
| Dec 31, 2019 | -5.88 Mn |
| Dec 31, 2019 | -5.88 Mn |
| Sep 30, 2019 | -6.20 Mn |
| Sep 30, 2019 | -6.20 Mn |
| Jun 30, 2019 | -5.50 Mn |
| Jun 30, 2019 | -5.50 Mn |
| Mar 31, 2019 | -5.45 Mn |
| Mar 31, 2019 | -5.45 Mn |
| Dec 31, 2018 | -5.87 Mn |
| Dec 31, 2018 | -5.87 Mn |
| Sep 30, 2018 | -6.26 Mn |
| Sep 30, 2018 | -6.26 Mn |
| Jun 30, 2018 | -9.33 Mn |
| Jun 30, 2018 | -9.33 Mn |
| Mar 31, 2018 | -5.40 Mn |
| Mar 31, 2018 | -5.40 Mn |
| Dec 31, 2017 | -6.35 Mn |
| Dec 31, 2017 | -6.35 Mn |
| Sep 30, 2017 | -11.78 Mn |
| Sep 30, 2017 | -11.78 Mn |
| Jun 30, 2017 | -12.64 Mn |
| Jun 30, 2017 | -12.64 Mn |
| Mar 31, 2017 | -13.86 Mn |
| Mar 31, 2017 | -13.86 Mn |
| Dec 31, 2016 | -11.43 Mn |
| Dec 31, 2016 | -11.43 Mn |
| Sep 30, 2016 | -12.73 Mn |
| Sep 30, 2016 | -12.73 Mn |
| Jun 30, 2016 | -11.55 Mn |
| Jun 30, 2016 | -11.55 Mn |
| Mar 31, 2016 | -12.50 Mn |
| Mar 31, 2016 | -12.50 Mn |
| Dec 31, 2015 | -9.03 Mn |
| Dec 31, 2015 | -9.03 Mn |
| Sep 30, 2015 | -9.83 Mn |
| Sep 30, 2015 | -9.83 Mn |
| Jun 30, 2015 | -8.82 Mn |
| Jun 30, 2015 | -8.82 Mn |
| Mar 31, 2015 | -9.37 Mn |
| Mar 31, 2015 | -9.37 Mn |
| Dec 31, 2014 | -6.98 Mn |
| Dec 31, 2014 | -6.98 Mn |
| Sep 30, 2014 | -5.57 Mn |
| Sep 30, 2014 | -5.57 Mn |